A detailed history of Newbridge Financial Services Group, Inc. transactions in Zoetis Inc. stock. As of the latest transaction made, Newbridge Financial Services Group, Inc. holds 98 shares of ZTS stock, worth $16,140. This represents 0.01% of its overall portfolio holdings.

Number of Shares
98
Previous 110 10.91%
Holding current value
$16,140
Previous $19,000 -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$172.58 - $196.48 $2,070 - $2,357
-12 Reduced 10.91%
98 $19,000
Q2 2024

Sep 11, 2024

SELL
$145.54 - $178.83 $21,103 - $25,930
-145 Reduced 56.86%
110 $19,000
Q4 2023

Mar 28, 2024

SELL
$151.44 - $200.09 $7,269 - $9,604
-48 Reduced 15.84%
255 $50,000
Q3 2023

Oct 17, 2023

SELL
$167.14 - $192.77 $10,696 - $12,337
-64 Reduced 17.44%
303 $52,000
Q2 2023

Jul 21, 2023

BUY
$160.94 - $186.23 $160 - $186
1 Added 0.27%
367 $63,000
Q1 2023

Apr 18, 2023

BUY
$145.48 - $175.02 $9,310 - $11,201
64 Added 21.19%
366 $60,000
Q4 2022

Jan 17, 2023

BUY
$131.14 - $157.47 $21,113 - $25,352
161 Added 114.18%
302 $0
Q3 2022

Oct 13, 2022

SELL
$148.29 - $182.55 $296 - $365
-2 Reduced 1.4%
141 $21,000
Q2 2022

Jul 15, 2022

SELL
$155.97 - $200.09 $25,579 - $32,814
-164 Reduced 53.42%
143 $25,000
Q1 2022

Apr 26, 2022

SELL
$181.39 - $234.03 $3,809 - $4,914
-21 Reduced 6.4%
307 $58,000
Q4 2021

Jan 19, 2022

BUY
$193.69 - $247.03 $3,873 - $4,940
20 Added 6.49%
328 $80,000
Q3 2021

Oct 27, 2021

BUY
$189.29 - $209.69 $9,085 - $10,065
48 Added 18.46%
308 $60,000
Q1 2021

Sep 07, 2021

BUY
$144.0 - $169.39 $5,760 - $6,775
40 Added 18.18%
260 $41,000
Q4 2020

Sep 07, 2021

BUY
$157.07 - $174.35 $2,198 - $2,440
14 Added 6.8%
220 $36,000
Q3 2020

Sep 07, 2021

BUY
$137.1 - $165.37 $28,242 - $34,066
206 New
206 $34,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.1B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Newbridge Financial Services Group, Inc. Portfolio

Follow Newbridge Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.